Classifying and Reporting Acquired Copy Number Variants (CNVs) and Copy Neutral Loss of Heterozygosity (CN-LOH) in Neoplastic Disorders: Joint Recommendations From the American College of Medical Genetics and Genomics (ACMG), and the Cancer Genomics Consortium (CGC)
Technical laboratory standards for interpretation and reporting
of acquired copy-number abnormalities and copy-neutral loss of heterozygosity in
neoplastic disorders: a joint consensus recommendation from the American College of
Medical Genetics and Genomics (ACMG) and the Cancer Genomics Consortium
(CGC)
Keyword(s):
Keyword(s):
Keyword(s):
